Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases

The liver is the largest metabolic organ in the human body, and impaired liver function can lead to a variety of acute and chronic liver diseases, which can affect the quality of life in mild cases or be life-threatening in severe cases. Therefore, it is important to explore accurate and effective m...

Full description

Bibliographic Details
Main Author: YUAN Xiwei, NAN Yuemin
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2023-10-01
Series:Zhongguo quanke yixue
Subjects:
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/20230146.pdf
_version_ 1797216551837892608
author YUAN Xiwei, NAN Yuemin
author_facet YUAN Xiwei, NAN Yuemin
author_sort YUAN Xiwei, NAN Yuemin
collection DOAJ
description The liver is the largest metabolic organ in the human body, and impaired liver function can lead to a variety of acute and chronic liver diseases, which can affect the quality of life in mild cases or be life-threatening in severe cases. Therefore, it is important to explore accurate and effective molecular diagnostic markers and therapeutic targets. Mitofusin 2 (Mfn2) is a transmembrane motor protein on the outer membrane of mitochondria, and plays an important role not only in mitochondrial fusion regulation, but also in cell energy metabolism, cell apoptosis, cell proliferation, mitochondrial endoplasmic reticulum (ER) connections, ER stress and mitochondrial autophagy, etc. It has been found that abnormal expression or function loss of Mfn2 can lead to abnormal mitochondrial function, which in turn leads to a variety of liver diseases. In this paper, a systematic review of the structure and function of Mfn2 and its mechanisms of action in liver diseases was conducted and found that Mfn2 can be involved in the development of chronic liver diseases through multiple pathways, and improve liver function through modulating Mfn2 overexpression to further slow down and reverse disease progression. This paper aims to provide a scientific reference for basic research of Mfn2 and liver diseases, as well as its clinical application.
first_indexed 2024-04-24T11:47:46Z
format Article
id doaj.art-2e5fa37bc84d4bcab1ab2f5f1d198904
institution Directory Open Access Journal
issn 1007-9572
language zho
last_indexed 2024-04-24T11:47:46Z
publishDate 2023-10-01
publisher Chinese General Practice Publishing House Co., Ltd
record_format Article
series Zhongguo quanke yixue
spelling doaj.art-2e5fa37bc84d4bcab1ab2f5f1d1989042024-04-09T08:44:32ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722023-10-0126303841384610.12114/j.issn.1007-9572.2023.0146Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver DiseasesYUAN Xiwei, NAN Yuemin01. Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China;2. Hebei Province Key Laboratory of Study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, ChinaThe liver is the largest metabolic organ in the human body, and impaired liver function can lead to a variety of acute and chronic liver diseases, which can affect the quality of life in mild cases or be life-threatening in severe cases. Therefore, it is important to explore accurate and effective molecular diagnostic markers and therapeutic targets. Mitofusin 2 (Mfn2) is a transmembrane motor protein on the outer membrane of mitochondria, and plays an important role not only in mitochondrial fusion regulation, but also in cell energy metabolism, cell apoptosis, cell proliferation, mitochondrial endoplasmic reticulum (ER) connections, ER stress and mitochondrial autophagy, etc. It has been found that abnormal expression or function loss of Mfn2 can lead to abnormal mitochondrial function, which in turn leads to a variety of liver diseases. In this paper, a systematic review of the structure and function of Mfn2 and its mechanisms of action in liver diseases was conducted and found that Mfn2 can be involved in the development of chronic liver diseases through multiple pathways, and improve liver function through modulating Mfn2 overexpression to further slow down and reverse disease progression. This paper aims to provide a scientific reference for basic research of Mfn2 and liver diseases, as well as its clinical application.https://www.chinagp.net/fileup/1007-9572/PDF/20230146.pdfmitochondrial dynamics|mitochondrial fusion 2|structure|function|liver disease|review
spellingShingle YUAN Xiwei, NAN Yuemin
Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
Zhongguo quanke yixue
mitochondrial dynamics|mitochondrial fusion 2|structure|function|liver disease|review
title Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
title_full Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
title_fullStr Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
title_full_unstemmed Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
title_short Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases
title_sort research progress of structure function and mechanism of action of mitofusin 2 in liver diseases
topic mitochondrial dynamics|mitochondrial fusion 2|structure|function|liver disease|review
url https://www.chinagp.net/fileup/1007-9572/PDF/20230146.pdf
work_keys_str_mv AT yuanxiweinanyuemin researchprogressofstructurefunctionandmechanismofactionofmitofusin2inliverdiseases